A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.
Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...
The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...
For a drug company, it is a huge economical decision to choose ... and the health of our nation that the Trump administration ...
WTIC Hartford on MSN2d
Legislative task force pushes to lower prescription drug costs in ConnecticutA bipartisan legislative task force is out with new recommendations to make the cost of prescription medicine easier on the ...
Assembly Bill 44 expands the state’s existing Unfair Trade Practice Act to include knowingly deceptive price fixing of ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
NPPA to consider other sources also to fix ceiling prices of some formulations: Gireesh Babu, New Delhi Monday, March 10, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...
The price-fixing investigation is in very early stages and targets large egg producers such as Cal-Maine Foods and Rose Acre Farms, the people said. The Capitol Forum first reported the DOJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback